Neovasc Inc (NVCN)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Neovasc Inc (NVCN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011215
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neovasc Inc (Neovasc) is a medical device company that develops, manufactures and sells products for cardiovascular disease. The company offers products such as tiara, reducer and tissue products. Its tiara is a novel transcatheter device that is designed for treating mitral regurgitation, a condition that is often severe and can lead to heart failure and death. Neovasc’s reducer is used for the treating refractory angina. The company’s reducer procedure uses standard catheter-based techniques. It operates in Canada and the US. Neovasc is headquartered in Richmond, British Columbia, Canada.

Neovasc Inc (NVCN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Neovasc Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Neovasc Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Neovasc Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Neovasc Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Neovasc Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Neovasc Inc, Medical Equipment, Deal Details 11
Equity Offering 11
Neovasc Raises USD37.5 Million in Public Offering of Units 11
Neovasc Raises USD75 Million in Public Offering of Shares 13
Neovasc Completes Public Offering Of Shares For US$22.7 Million 14
Neovasc Completes Private Placement Of Shares For US$2.2 Million Upon Exercise Of Warrants 15
Neovasc Completes Non-Brokered Private Placement Of Units For US$5 Million 16
Debt Offering 18
Neovasc Raises USD27.83 Million in Private Placement of Notes Due 2018 and Warrants 18
Asset Transactions 19
Boston Scientific Acquires Tissue Processing Technology and Facility from Neovasc for USD68 Million 19
LeMaitre Vascular Finalizes Acquisition of XenoSure From Neovasc For US$5 Million 20
Acquisition 22
Boston Scientific Acquires 15% Stake in Neovasc for USD7 Million 22
Fidelity Acquires 30% Stake in Neovasc from Peregrine Ventures 24
Neovasc Inc – Key Competitors 25
Neovasc Inc – Key Employees 26
Neovasc Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
Nov 14, 2017: Neovasc Announces Results for the Third Quarter of 2017 28
Aug 10, 2017: Neovasc Announces Results for the Second Quarter of 2017 31
May 10, 2017: Neovasc Announces Results for the First Quarter of 2017 34
Mar 23, 2017: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2016 36
Nov 14, 2016: Neovasc Reports Third Quarter Results for 2016 39
Aug 09, 2016: Neovasc Reports Second Quarter Results for 2016 41
Apr 29, 2016: Neovasc Reports First Quarter Results for 2016 44
Mar 29, 2016: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2015 47
Legal and Regulatory 50
Nov 03, 2017: Neovasc Provides Litigation Update 50
Mar 10, 2017: Neovasc Announces TSX Symbol Change to NVCN 51
Jan 18, 2017: Neovasc Announces Update in Litigation with CardiAQ 52
Jul 05, 2016: Neovasc Receives NASDAQ Notification Regarding Minimum Bid Requirements 53
May 19, 2016: Neovasc Announces Jury Verdict in Litigation Brought by CardiAQ 54
Product News 55
01/11/2016: Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial 55
Product Approvals 56
Jan 11, 2016: Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57

List of Tables
Neovasc Inc, Medical Equipment, Key Facts, 2016 2
Neovasc Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Neovasc Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Neovasc Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Neovasc Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Neovasc Inc, Deals By Market, 2011 to YTD 2017 9
Neovasc Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Neovasc Raises USD37.5 Million in Public Offering of Units 11
Neovasc Raises USD75 Million in Public Offering of Shares 13
Neovasc Completes Public Offering Of Shares For US$22.7 Million 14
Neovasc Completes Private Placement Of Shares For US$2.2 Million Upon Exercise Of Warrants 15
Neovasc Completes Non-Brokered Private Placement Of Units For US$5 Million 16
Neovasc Raises USD27.83 Million in Private Placement of Notes Due 2018 and Warrants 18
Boston Scientific Acquires Tissue Processing Technology and Facility from Neovasc for USD68 Million 19
LeMaitre Vascular Finalizes Acquisition of XenoSure From Neovasc For US$5 Million 20
Boston Scientific Acquires 15% Stake in Neovasc for USD7 Million 22
Fidelity Acquires 30% Stake in Neovasc from Peregrine Ventures 24
Neovasc Inc, Key Competitors 25
Neovasc Inc, Key Employees 26
Neovasc Inc, Subsidiaries 27

★海外企業調査レポート[Neovasc Inc (NVCN)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Qurate Retail Inc (QRTEA):企業の財務・戦略的SWOT分析
    Qurate Retail Inc (QRTEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Just Group plc:戦略・SWOT・企業財務分析
    Just Group plc - Strategy, SWOT and Corporate Finance Report Summary Just Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sumitomo Mitsui Construction Co Ltd (1821):企業の財務・戦略的SWOT分析
    Sumitomo Mitsui Construction Co Ltd (1821) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Fanuc Corp (6954):企業の財務・戦略的SWOT分析
    Fanuc Corp (6954) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Navitas Ltd:企業の戦略的SWOT分析
    Navitas Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • maxingvest ag:企業の戦略・SWOT・財務情報
    maxingvest ag - Strategy, SWOT and Corporate Finance Report Summary maxingvest ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Johns Hopkins University:医療機器:M&Aディール及び事業提携情報
    Summary Johns Hopkins University (JHU) is a research university which offers undergraduate, graduate, master’s, and doctoral programs. It offers educational services in the areas of arts and sciences, engineering, business, medicine, nursing, public health, and advanced international studies. It als …
  • Vancouver City Savings Credit Union:企業の戦略・SWOT・財務情報
    Vancouver City Savings Credit Union - Strategy, SWOT and Corporate Finance Report Summary Vancouver City Savings Credit Union - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Rothschild Bank AG:企業の戦略・SWOT・財務情報
    Rothschild Bank AG - Strategy, SWOT and Corporate Finance Report Summary Rothschild Bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Baptist Memorial Health Care Corp:企業の戦略的SWOT分析
    Baptist Memorial Health Care Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • TALi Digital Ltd (NHL):企業の財務・戦略的SWOT分析
    TALi Digital Ltd (NHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Tyson Foods Inc:企業のM&A・事業提携・投資動向
    Tyson Foods Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tyson Foods Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • ADC Therapeutics SA:製薬・医療:M&Aディール及び事業提携情報
    Summary ADC Therapeutics SA (ADCT) is a pharmaceutical company that develops a pipeline of proprietary antibody drug conjugates for the treatment of both solid and hematological cancers. The company offers combining monoclonal antibodies specific to particular types of tumor cells with a novel class …
  • Acura Pharmaceuticals Inc (ACUR)-製薬・医療分野:企業M&A・提携分析
    Summary Acura Pharmaceuticals Inc (Acura) is a specialty pharmaceutical company that researches, develops, and commercializes tamper-resistant products to prevent the abuse and misuse of medication. The company’s proprietary technologies, Aversion, Limitx and Impede, are used to prevent product tamp …
  • Asahi Kasei Corp (3407):企業の財務・戦略的SWOT分析
    Asahi Kasei Corp (3407) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Medical Prognosis Institute A/S (MPI):企業の財務・戦略的SWOT分析
    Summary Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers drug response prediction platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue …
  • The Charles Schwab Corporation:戦略・SWOT・企業財務分析
    The Charles Schwab Corporation - Strategy, SWOT and Corporate Finance Report Summary The Charles Schwab Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Croma Security Solutions Group plc (CSSG):企業の財務・戦略的SWOT分析
    Croma Security Solutions Group plc (CSSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • LG Chem Ltd (051910):企業の財務・戦略的SWOT分析
    LG Chem Ltd (051910) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆